BGMA Sets Out Suggestions For VPAS Overhaul

Generics Body Urges Recognition Of Specificities Of The Off-Patent Medicines Market

 
• By David Wallace
  
Two pound coins surrounded by tablets and capsules
VPAS risks making some off-patent medicines unprofitable • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin